About
TruDiagnostic provides epigenetic testing to measure biological age and health across key systems. Their tests, like TruAge and TruHealth, analyze DNA methylation from blood samples to deliver precise insights into aging pace, organ function, and nutritional status. Users gain a clear view of cellular health to guide measured steps toward optimization.
TruAge assesses over 900,000 methylation markers for metrics such as telomere length, epigenetic age, and DunedinPACE rate of aging. TruHealth evaluates 105+ biomarkers across 19 categories, covering vitamins, antioxidants, inflammation, toxins, and neurocognitive factors. This integrated approach supports strategic health decisions based on personal biology.
The company focuses on reliable, evidence-based analysis through partnerships with institutions like Harvard and Duke. They develop new epigenetic tools to expand understanding of biological function. Their work enables sustainable progress in health optimization.
Longevity Contribution
- Analyzes over 900,000 methylation markers and 105+ biomarkers for comprehensive epigenetic insights.
- Licenses exclusive algorithms like DunedinPACE from Duke and Mitotic Clock from Van Andel Institute.
- Developed over 1,670 Epigenetic Biomarkers™ in partnership with Harvard for superior predictive accuracy.
- Maintains the largest private epigenetic database to create precise health and aging tools.
